Drugmakers have poured small fortunes into the development of weight loss medicines in the past few years in attempts to lead ...
Once home, I was convinced I’d never sleep again for fear of more episodes of apnea. We purchased a specialized baby monitor ...
The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...
Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a thumbs-up to Alyftrek in treating ...
Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take ...
From Aug. 1 to the end of the year, Medicaid beneficiaries received 33,035 claims for GLP-1 drugs for weight loss, a number ...
Tariffs may sound tough, but America’s fentanyl crisis stems from a decades-long addiction problem that trade policy can’t ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...
The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...
The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.
The Police Scotland campaign ran from 1 December until 19 January. Community referrals for help with issues with substance use are on the rise in Guernsey, a charity says More than 3,000 people ...